"A part of the Lifespan health care system, Newport Hospital is a private, not-for-profit hospital with a history of providing superior patient care. The Miriam Hospital offers a wide range of medical services, with notable expertise in cardiac care, total joint replacement, bariatric surgery, minimally invasive and robotic surgery and men's health. The emergency department is staffed 24 hours a day, 365 days a year, by physicians, nurses and other critical staff who are committed to providing superior patient-centered care in a comfortable and compassionate environment."

During the past decade, Newport Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newport Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Newport Hospital" are "Breast Carcinoma" (2 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (2 trials), "Stage IIA Lung Non-Small Cell Carcinoma AJCC v7" (2 trials) and "Stage IIB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials). Many other conditions were trialed in "Newport Hospital" in a lesser frequency.

Most popular intervention types in "Newport Hospital" are "Drug" (7 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Clinical Observation" (3 trials), "Computed Tomography" (3 trials), "Crizotinib" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Newport Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Newport Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Newport Hospital, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Newport Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".